Acyclovir therapy for mucocutaneous herpes simplex infections in immunocompromised patients.

@article{Mitchell1981AcyclovirTF,
  title={Acyclovir therapy for mucocutaneous herpes simplex infections in immunocompromised patients.},
  author={Christopher D. Mitchell and Brent Bean and S R Gentry and K E Groth and James R Boen and Henry H. Balfour},
  journal={Lancet},
  year={1981},
  volume={1 8235},
  pages={1389-92}
}
11 of 24 immunocompromised patients with mucocutaneous herpes simplex virus (HSV) infections were given intravenous acyclovir in a randomised double-blind placebo-controlled study. Patients receiving acyclovir experienced no major adverse effects. The median times to cessation of new lesion formation, lesion crusting, lesion healing, cessation of pain, and… CONTINUE READING